Product Pipeline

Other Product Candidates

Our combined hormonal contraceptive (CHC) pipeline includes the following Twirla line extensions:

  • AG200-SP is a novel regimen designed to allow women to experience shorter, lighter periods. The planned AG200-SP regimen will include the use of Twirla for three weeks followed by the use of a smaller lower-dose patch in the fourth week of the woman's cycle.
  • AG200-ER is an extended cycle regimen utilizing Twirla that allows a woman to extend the time between her episodes of withdrawal bleeding
  • AG200-ER (SmP) is an extended cycle regimen utilizing both Twirla and a smaller lower-dose patch

Our Progestin-only, or P-only, pipeline includes the following product candidate:

  • AG890 is a levonorgestrel-only contraceptive patch, developed for potential use by women who are unable or unwilling to take estrogen, including those who are breastfeeding or who are at greater risk of VTE, such as women who smoke, are over 35 years of age, or who are obese.